Anrotinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anrotinib, covering 2022-01-10 to 2023-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Anrotinib and Tirelizumab in First-line Treatment of RM-NPC [Phase 2]